Abstracts and ePosters: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent
ESMO Breast Cancer 2024
- Start date
- 15 May 2024
- End date
- 17 May 2024
- Location
- Berlin, Germany
ESMO Breast Cancer 2024 took place as a hybrid meeting, onsite in Berlin, Germany, on 15-17 May 2024, and online, through a virtual platform.
ESMO Breast Cancer is a congress designed for breast cancer researchers and clinicians with a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care.
Attendees to the 2024 edition gained insights on:
- Recent developments in novel diagnostics, biomarkers and treatments in breast cancer
- Updates on the rapid development of novel antibody drug conjugates for breast cancer
- New strategies for Luminal, HER2 positive, HER2-low and triple negative breast cancer
- Special considerations for different subgroups of patients with breast cancer
Photo Gallery
Programme
The ESMO Breast Cancer 2024 programme is online!
Certificate of Attendance
Download your certificate from your ESMO area
Abstracts
The abstract submission system is now closed
Information for Presenters
Find here instructions to assist with your presentation
Supporters
Find out more information about the supporters of ESMO Breast Cancer 2024
Exhibition
ESMO Breast Cancer 2024 Exhibition delivers a comprehensive overview of breast cancer data for a clear clinic roadmap
Industry Participation
Industry partners: find out how to get involved
Venue
The ESMO Breast Cancer 2024 will take place at the hub27 – Messe Berlin in Berlin, Germany
Press & Media
Information for media representatives
Social Media
Follow #ESMOBreast24 on Facebook, X (Twitter), LinkedIn, Instagram and YouTube
Contacts
Contact information for the event organisers
Practical Information
Frequently Asked Questions